Drugmaker Eli Lilly said Tuesday it will sell single-use vials of its weight-loss drug Zepbound at a fraction of the price of its pens, amid skyrocketing demand among Americans for anti-obesity ...
INDIANAPOLIS — Eli Lilly is releasing single-dose vials of weight loss drug Zepbound that will help adults living with obesity. Zepbound 2.5 mg and 5 mg single-dose vials are available for patients ...
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage for ...
Eli Lilly has released a cheaper version of its weight-loss drug Zepbound. It will now be available in single-dose vials at about half the price. Instead of using prefilled injection pens, people will ...
Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity Lilly has created a new self-pay ...
With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499/month or less, regardless of insurance status, under Zepbound Self Pay ...
Eli Lilly says weight-loss drug Zepbound now available in 2.5- and 5-milligram vials at 50% discount
Drug company says vials are available through its LillyDirect digital platform with on-label prescription Eli Lilly & Co. (LLY) said Tuesday that patients can now access 2.5- and 5-milligram ...
Distributed through LillyDirect ® 's self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity INDIANAPOLIS, Aug. 27, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback